The share of HIV-positive tuberculosis patients on antiretroviral therapy in Brazil is forecasted to decline from an estimated 37% in 2024 to 26% by 2028. This suggests a concerning trend with a consistent year-on-year decrease over the upcoming years. The sharpest decline is noticeable between 2024 and 2028, averaging an annual decrease of approximately 8.4%.
Future trends to watch for include:
- Potential interventions by Brazilian health authorities to address and reverse this declining trend.
- Impact of international guidelines and support in improving antiretroviral therapy adherence.
- Advancements in medical technologies that could enhance patient outcomes for co-infected individuals.
